Your browser doesn't support javascript.
loading
NUDCD3 deficiency disrupts V(D)J recombination to cause SCID and Omenn syndrome.
Chen, Rui; Lukianova, Elena; van der Loeff, Ina Schim; Spegarova, Jarmila Stremenova; Willet, Joseph D P; James, Kieran D; Ryder, Edward J; Griffin, Helen; IJspeert, Hanna; Gajbhiye, Akshada; Lamoliatte, Frederic; Marin-Rubio, Jose L; Woodbine, Lisa; Lemos, Henrique; Swan, David J; Pintar, Valeria; Sayes, Kamal; Ruiz-Morales, Elias R; Eastham, Simon; Dixon, David; Prete, Martin; Prigmore, Elena; Jeggo, Penny; Boyes, Joan; Mellor, Andrew; Huang, Lei; van der Burg, Mirjam; Engelhardt, Karin R; Stray-Pedersen, Asbjørg; Erichsen, Hans Christian; Gennery, Andrew R; Trost, Matthias; Adams, David J; Anderson, Graham; Lorenc, Anna; Trynka, Gosia; Hambleton, Sophie.
Afiliação
  • Chen R; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Lukianova E; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.
  • van der Loeff IS; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Spegarova JS; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, NE1 4LP Newcastle upon Tyne, UK.
  • Willet JDP; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • James KD; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Ryder EJ; Institute of Immunology and Immunotherapy, University of Birmingham. B15 2TT Birmingham, UK.
  • Griffin H; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.
  • IJspeert H; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Gajbhiye A; Department of Immunology, Erasmus University Medical Center, Rotterdam 3000 CA, Netherlands.
  • Lamoliatte F; Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Marin-Rubio JL; Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Woodbine L; Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Lemos H; Genome Damage and Stability Centre, University of Sussex, BN1 9RQ Brighton, UK.
  • Swan DJ; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Pintar V; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Sayes K; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Ruiz-Morales ER; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Eastham S; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.
  • Dixon D; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.
  • Prete M; Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Prigmore E; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.
  • Jeggo P; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.
  • Boyes J; Genome Damage and Stability Centre, University of Sussex, BN1 9RQ Brighton, UK.
  • Mellor A; Faculty of Biological Sciences, University of Leeds, LS2 9JT Leeds, UK.
  • Huang L; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • van der Burg M; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Engelhardt KR; Department of Immunology, Erasmus University Medical Center, Rotterdam 3000 CA, Netherlands.
  • Stray-Pedersen A; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Erichsen HC; Norwegian National Unit for Newborn Screening, Division of Pediatric and Adolescent Medicine, Oslo University Hospital, Oslo 0424, Norway.
  • Gennery AR; Division of Pediatric and Adolescent Medicine, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo 0424, Norway.
  • Trost M; Translational and Clinical Research Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Adams DJ; Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, NE1 4LP Newcastle upon Tyne, UK.
  • Anderson G; Biosciences Institute, Newcastle University, NE2 4HH Newcastle upon Tyne, UK.
  • Lorenc A; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.
  • Trynka G; Institute of Immunology and Immunotherapy, University of Birmingham. B15 2TT Birmingham, UK.
  • Hambleton S; Wellcome Sanger Institute, Wellcome Genome Campus, CB10 1SA Hinxton, UK.
Sci Immunol ; 9(95): eade5705, 2024 May 24.
Article em En | MEDLINE | ID: mdl-38787962
ABSTRACT
Inborn errors of T cell development present a pediatric emergency in which timely curative therapy is informed by molecular diagnosis. In 11 affected patients across four consanguineous kindreds, we detected homozygosity for a single deleterious missense variant in the gene NudC domain-containing 3 (NUDCD3). Two infants had severe combined immunodeficiency with the complete absence of T and B cells (T -B- SCID), whereas nine showed classical features of Omenn syndrome (OS). Restricted antigen receptor gene usage by residual T lymphocytes suggested impaired V(D)J recombination. Patient cells showed reduced expression of NUDCD3 protein and diminished ability to support RAG-mediated recombination in vitro, which was associated with pathologic sequestration of RAG1 in the nucleoli. Although impaired V(D)J recombination in a mouse model bearing the homologous variant led to milder immunologic abnormalities, NUDCD3 is absolutely required for healthy T and B cell development in humans.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunodeficiência Combinada Severa / Recombinação V(D)J Limite: Animals / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Sci Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunodeficiência Combinada Severa / Recombinação V(D)J Limite: Animals / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Sci Immunol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido